Cytomegalovirus hyperimmunoglobulin and substitution with blood products from antibody-negative donors. A pilot study in bone marrow transplant recipients.
D000208:Acute Disease; D000328:Adult; D001782:Blood Donors; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D006082:Graft Enhancement, Immunologic; D006801:Humans; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000150:complications / Q000628:therapy*; D008297:Male; D010865:Pilot Projects; D014916:Whole-Body Irradiation
D003520:Cyclophosphamide